Nalls Sherbakoff Group »

ResMed shares owned by Nalls Sherbakoff Group

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Nalls Sherbakoff Group from 13F filings

Historical chart of Nalls Sherbakoff Group investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Nalls Sherbakoff Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Nalls Sherbakoff Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4k 14 172.07
2023-09-30 $2.1k 14 147.93
2023-06-30 $3.0k 14 210.86
2023-03-31 $3.0k 14 216.00

More positions owned by Nalls Sherbakoff Group

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Index Fds Real Estate Etf (VNQ)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Apple (AAPL)
Capstar Finl Hldgs
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Value Etf (VTV)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Invesco Exch Traded Fd Tr Ii Ftse Rafi Dev (PXF)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)

View all positions for Nalls Sherbakoff Group

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Invesco
Northern Trust
Legal & General Group
Select Equity
Charles Schwab Investment Management
Goldman Sachs Group
Ubs Global Asset Management Americas
Greenvale Capital
Dimensional Fund Advisors
Jpmorgan Chase & Co

View all funds holding ResMed